Note 17 - Subsequent Events	12 Months Ended
Dec. 31, 2016
Subsequent Events [Abstract]
Note 17 - Subsequent Events	On January 11, 2017, the Company sold one property for $194,000. On February 14 2017, the Company sold one property for $258,500. On March 1, 2017, the Company entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”), a company focused on the production of certified organic cannabidol oil (“CBD”). The transaction closed on March 13, 2017 and, pursuant to the agreement, the Company issued 10,000,000 shares of its restricted common stock in exchange for all the issued and outstanding shares of IXB. As a result of the Stock Exchange Agreement the Company will become IXB’s sole shareholder, making IXB a subsidiary of the Company. In conjunction with the closing of the Stock Exchange Agreement, the Company has restructured its Board of Directors resulting in Michael Ogburn being appointed its new Chairman of the Board, Chief Executive Officer and Chief Financial Officer, and has also appointed two new directors, Joaquin Flores and Brian Werner. On March 13, 2017, the Board of Directors adopted the Company’s Second Amended Bylaws, forming the Real Estate Committee (the “Committee”). The Committee will be charged with managing all business-related matters regarding the Company’s real estate holdings. Directors Sean Zarinegar, Kenneth Hedrick, and Les Gutierrez were appointed to serve as members of the Committee. On March 13, 2017, the Company sold one property for $75,000. Subsequent to the year ended December 31, 2016, the Company received proceeds of $83,166 pursuant to stock subscription agreements, whereby the Company issued 83,166 shares of common stock of the Company. Subsequent to the year ended December 31, 2016, the Company received proceeds of $50,000 pursuant to stock subscription agreements, whereby the Company will issue 50,000 shares of common stock of the Company.

Note 17 - Subsequent Events

12 Months Ended

Dec. 31, 2016

On January 11, 2017, the Company sold one property for $194,000.

On February 14 2017, the Company sold one property for $258,500.

On March 1, 2017, the Company entered into a Stock Exchange Agreement with IX Biotechnology, Inc. (“IXB”), a company focused on the production of certified organic cannabidol oil (“CBD”). The transaction closed on March 13, 2017 and, pursuant to the agreement, the Company issued 10,000,000 shares of its restricted common stock in exchange for all the issued and outstanding shares of IXB. As a result of the Stock Exchange Agreement the Company will become IXB’s sole shareholder, making IXB a subsidiary of the Company. In conjunction with the closing of the Stock Exchange Agreement, the Company has restructured its Board of Directors resulting in Michael Ogburn being appointed its new Chairman of the Board, Chief Executive Officer and Chief Financial Officer, and has also appointed two new directors, Joaquin Flores and Brian Werner.

On March 13, 2017, the Board of Directors adopted the Company’s Second Amended Bylaws, forming the Real Estate Committee (the “Committee”). The Committee will be charged with managing all business-related matters regarding the Company’s real estate holdings. Directors Sean Zarinegar, Kenneth Hedrick, and Les Gutierrez were appointed to serve as members of the Committee.

On March 13, 2017, the Company sold one property for $75,000.

Subsequent to the year ended December 31, 2016, the Company received proceeds of $83,166 pursuant to stock subscription agreements, whereby the Company issued 83,166 shares of common stock of the Company.

Subsequent to the year ended December 31, 2016, the Company received proceeds of $50,000 pursuant to stock subscription agreements, whereby the Company will issue 50,000 shares of common stock of the Company.